HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R G Hart Selected Research
R G Hart Research Topics
Disease
12
Stroke (Strokes)
06/2013 - 01/2000
8
Atrial Fibrillation
06/2013 - 01/2000
6
Ischemic Stroke
01/2020 - 01/2000
4
Hemorrhage
01/2020 - 01/2000
2
Embolic Stroke
01/2020 - 01/2000
2
Cerebral Hemorrhage
11/2001 - 10/2000
2
Myocardial Infarction
08/2001 - 03/2000
1
Neoplasms (Cancer)
01/2020
1
Hemorrhagic Stroke
10/2010
1
Albuminuria
10/2010
1
Heart Failure
06/2005
1
Left Ventricular Dysfunction
06/2005
1
Parkinson Disease (Parkinson's Disease)
04/2003
1
Brain Ischemia (Cerebral Ischemia)
07/2000
1
Vascular Diseases (Vascular Disease)
03/2000
1
Intracranial Hemorrhages (Intracranial Hemorrhage)
03/2000
Drug/Important Bio-Agent (IBA)
9
Aspirin (Acetylsalicylic Acid)
FDA Link
Generic
01/2020 - 01/2000
6
Warfarin (Coumadin)
FDA Link
Generic
06/2013 - 01/2000
2
Fibrinolytic Agents (Antithrombotic Agents)
IBA
03/2001 - 01/2000
1
Rivaroxaban
IBA
01/2020
1
Phenprocoumon (Liquamar)
FDA Link
06/2013
1
Anticoagulants
IBA
06/2013
1
apixaban
IBA
06/2013
1
Vitamin K
FDA Link
06/2013
1
Dabigatran
FDA Link
05/2012
1
Biomarkers (Surrogate Marker)
IBA
10/2010
1
Cystatin C
IBA
10/2010
1
Creatinine
IBA
10/2010
1
Albumins
IBA
10/2010
1
spermatogenesis associated factor (SPAF)
IBA
06/2005
1
von Willebrand Factor
IBA
06/2005
1
P-Selectin
IBA
06/2005
1
Neuroprotective Agents
IBA
04/2003
1
saruplase
IBA
11/2001
1
Blood Glucose (Blood Sugar)
IBA
11/2001
Therapy/Procedure
9
Therapeutics
08/2001 - 01/2000
3
Secondary Prevention
01/2020 - 03/2000
1
Aftercare (After-Treatment)
11/2001